Ebola is rare, deadly and has multiple variations. There is a vaccine for the Zaire type, now trials for another are underway ...

Makerere University, the Uganda Virus Research Institute and the WHO got the Ebola vaccine trial ready for dosing in just ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

The vaccine candidate is being evaluated in a ring vaccination trial as part of a comprehensive public health response ...

Six species of the virus are known to cause disease in humans -- Zaire, Sudan, Bundibugyo, Reston, Tai Forest and Bombali.

Ugandan health officials on Thursday confirmed a case of Ebola in the capital Kampala, in a nurse who sought care at a number ...

Two vaccines -- Merck's Ervebo and Johnson & Johnson's two-dose Zabdeno -- have been approved for use against the Zaire Ebola strain. The DRC's health authorities have said vaccines helped slow ...

After studies and national approvals, the vaccine, Ervebo, was deployed during an outbreak in the Democratic Republic of Congo in 2018, and met with success. The vaccine has since been licensed in ...

Two vaccines -- Merck's Ervebo and Johnson & Johnson's two-dose Zabdeno -- have been approved for use against the Zaire Ebola strain. The DRC's health authorities have said vaccines helped slow the ...

The new vaccine – known during its development as V920 (rVSVΔG-ZEBOV-GP) – will be distributed under the Ervebo brand name if approved by the EMA for active immunisation of individuals aged ...